Clinical Trial Update: Sipuleucel-T as Neoadjuvant Treatment in Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 study evaluating sipuleucel-T as neoadjuvant therapy for prostate cancer has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• sipuleucel-T (sipuleucel-T)

Snippet

Sponsor: Dendreon | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED | Results posted: 2015-04-01